Cerus Total Liabilities 2010-2025 | CERS
Cerus total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Cerus Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $144 |
| 2023 | $144 |
| 2022 | $150 |
| 2021 | $152 |
| 2020 | $118 |
| 2019 | $108 |
| 2018 | $79 |
| 2017 | $59 |
| 2016 | $46 |
| 2015 | $45 |
| 2014 | $40 |
| 2013 | $41 |
| 2012 | $30 |
| 2011 | $27 |
| 2010 | $24 |
| 2009 | $13 |
| Cerus Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $151 |
| 2024-12-31 | $144 |
| 2024-09-30 | $135 |
| 2024-06-30 | $135 |
| 2024-03-31 | $139 |
| 2023-12-31 | $144 |
| 2023-09-30 | $157 |
| 2023-06-30 | $147 |
| 2023-03-31 | $150 |
| 2022-12-31 | $150 |
| 2022-09-30 | $141 |
| 2022-06-30 | $140 |
| 2022-03-31 | $141 |
| 2021-12-31 | $152 |
| 2021-09-30 | $138 |
| 2021-06-30 | $139 |
| 2021-03-31 | $128 |
| 2020-12-31 | $118 |
| 2020-09-30 | $104 |
| 2020-06-30 | $101 |
| 2020-03-31 | $103 |
| 2019-12-31 | $108 |
| 2019-09-30 | $104 |
| 2019-06-30 | $109 |
| 2019-03-31 | $106 |
| 2018-12-31 | $79 |
| 2018-09-30 | $70 |
| 2018-06-30 | $61 |
| 2018-03-31 | $59 |
| 2017-12-31 | $59 |
| 2017-09-30 | $60 |
| 2017-06-30 | $44 |
| 2017-03-31 | $43 |
| 2016-12-31 | $46 |
| 2016-09-30 | $44 |
| 2016-06-30 | $46 |
| 2016-03-31 | $44 |
| 2015-12-31 | $45 |
| 2015-09-30 | $40 |
| 2015-06-30 | $41 |
| 2015-03-31 | $33 |
| 2014-12-31 | $40 |
| 2014-09-30 | $32 |
| 2014-06-30 | $33 |
| 2014-03-31 | $28 |
| 2013-12-31 | $41 |
| 2013-09-30 | $44 |
| 2013-06-30 | $28 |
| 2013-03-31 | $31 |
| 2012-12-31 | $30 |
| 2012-09-30 | $32 |
| 2012-06-30 | $28 |
| 2012-03-31 | $33 |
| 2011-12-31 | $27 |
| 2011-09-30 | $20 |
| 2011-06-30 | $26 |
| 2011-03-31 | $27 |
| 2010-12-31 | $24 |
| 2010-09-30 | $20 |
| 2010-06-30 | $18 |
| 2010-03-31 | $16 |
| 2009-12-31 | $13 |
| 2009-09-30 | $17 |
| 2009-06-30 | $13 |
| 2009-03-31 | $12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.283B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.070B | 28.51 |
| Boston Scientific (BSX) | United States | $155.016B | 38.81 |
| Stryker (SYK) | United States | $151.431B | 31.66 |
| EssilorLuxottica (ESLOY) | France | $128.578B | 0.00 |
| Medtronic (MDT) | Ireland | $113.826B | 16.14 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.396B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.515B | 26.54 |
| ResMed (RMD) | United States | $37.575B | 28.22 |
| GE HealthCare Technologies (GEHC) | United States | $34.776B | 16.51 |
| Agilent Technologies (A) | United States | $34.216B | 22.31 |
| Terumo (TRUMY) | Japan | $26.620B | 34.58 |
| Koninklijke Philips (PHG) | Netherlands | $23.303B | 16.35 |
| Insulet (PODD) | United States | $21.112B | 82.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.610B | 11.95 |
| Baxter (BAX) | United States | $16.026B | 11.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.402B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.748B | 23.48 |
| Lantheus Holdings (LNTH) | United States | $5.495B | 13.86 |
| Prestige Consumer Healthcare (PBH) | United States | $3.969B | 17.73 |
| Perrigo (PRGO) | Ireland | $3.771B | 9.56 |
| Haemonetics (HAE) | United States | $3.667B | 16.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.393B | 28.20 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| QuidelOrtho (QDEL) | United States | $2.015B | 13.86 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 42.27 |
| AtriCure (ATRC) | United States | $1.594B | 0.00 |
| Acuren (TIC) | United States | $1.327B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.269B | 12.88 |
| Green Thumb Industries (GTBIF) | United States | $1.158B | 26.05 |
| Neogen (NEOG) | United States | $1.103B | 14.11 |
| Phibro Animal Health (PAHC) | United States | $1.079B | 13.79 |
| BioLife Solutions (BLFS) | United States | $1.029B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 9.45 |
| Kestra Medical Technologies (KMTS) | United States | $0.813B | 0.00 |
| Owens & Minor (OMI) | United States | $0.728B | 6.04 |
| CeriBell (CBLL) | United States | $0.671B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.443B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Surmodics (SRDX) | United States | $0.419B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.353B | 12.98 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.33 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| ZimVie (ZIMV) | United States | $0.274B | 12.46 |
| Cresco Labs (CRLBF) | United States | $0.258B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 64.88 |
| Aurora Cannabis (ACB) | Canada | $0.242B | 71.67 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.208B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.190B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Omeros (OMER) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.50 |
| TerrAscend (TSNDF) | Canada | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.75 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |